DE69917809D1 - Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz - Google Patents
Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenzInfo
- Publication number
- DE69917809D1 DE69917809D1 DE69917809T DE69917809T DE69917809D1 DE 69917809 D1 DE69917809 D1 DE 69917809D1 DE 69917809 T DE69917809 T DE 69917809T DE 69917809 T DE69917809 T DE 69917809T DE 69917809 D1 DE69917809 D1 DE 69917809D1
- Authority
- DE
- Germany
- Prior art keywords
- insulin resistance
- salts
- americ
- acid
- treating insulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010022489 Insulin Resistance Diseases 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000001384 succinic acid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU1999/000055 WO2000051594A1 (en) | 1999-03-01 | 1999-03-01 | Use of succinic acid or salts thereof and method of treating insulin resistance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69917809D1 true DE69917809D1 (de) | 2004-07-08 |
| DE69917809T2 DE69917809T2 (de) | 2004-11-04 |
Family
ID=20130328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69917809T Expired - Lifetime DE69917809T2 (de) | 1999-03-01 | 1999-03-01 | Verwendung von Bernsteinsäure oder deren Salze zur Behandlung von Insulinresistenz |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6521665B1 (de) |
| EP (1) | EP1156795B1 (de) |
| AT (1) | ATE268170T1 (de) |
| AU (1) | AU4937499A (de) |
| CA (1) | CA2366073A1 (de) |
| DE (1) | DE69917809T2 (de) |
| DK (1) | DK1156795T3 (de) |
| ES (1) | ES2222717T3 (de) |
| PT (1) | PT1156795E (de) |
| WO (1) | WO2000051594A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001076583A1 (en) * | 2000-04-10 | 2001-10-18 | Verteletsky, Pavel Vasilievich | Synergistic compositions containing choline base and succinic acid for insulin resistance and diabetes |
| CN101815515A (zh) * | 2007-08-02 | 2010-08-25 | 布达生物制药有限公司 | 含有琥珀酸的鼻内用药物组合物 |
| US20120107850A1 (en) * | 2009-07-15 | 2012-05-03 | Panasonic Corporation | Analysis reagent and analysis device having the analysis reagent carried therein |
| JP5460183B2 (ja) * | 2009-08-28 | 2014-04-02 | パナソニック株式会社 | 分析用試薬および分析用デバイス |
| KR20210024056A (ko) * | 2018-06-22 | 2021-03-04 | 엔진 바이오사이언스 리미티드 | 혈액 장애 치료를 위한 숙신산 및 유도체 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61171417A (ja) * | 1985-01-23 | 1986-08-02 | Wakunaga Seiyaku Kk | 抗糖尿病剤 |
| JP3581157B2 (ja) | 1992-08-19 | 2004-10-27 | 株式会社ミツカングループ本社 | 低耐糖能者用食品 |
-
1999
- 1999-03-01 WO PCT/RU1999/000055 patent/WO2000051594A1/en active IP Right Grant
- 1999-03-01 AT AT99933301T patent/ATE268170T1/de not_active IP Right Cessation
- 1999-03-01 ES ES99933301T patent/ES2222717T3/es not_active Expired - Lifetime
- 1999-03-01 AU AU49374/99A patent/AU4937499A/en not_active Abandoned
- 1999-03-01 CA CA002366073A patent/CA2366073A1/en not_active Abandoned
- 1999-03-01 DK DK99933301T patent/DK1156795T3/da active
- 1999-03-01 DE DE69917809T patent/DE69917809T2/de not_active Expired - Lifetime
- 1999-03-01 PT PT99933301T patent/PT1156795E/pt unknown
- 1999-03-01 EP EP99933301A patent/EP1156795B1/de not_active Expired - Lifetime
- 1999-03-01 US US09/914,499 patent/US6521665B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6521665B1 (en) | 2003-02-18 |
| EP1156795B1 (de) | 2004-06-02 |
| ATE268170T1 (de) | 2004-06-15 |
| AU4937499A (en) | 2000-09-21 |
| WO2000051594A1 (en) | 2000-09-08 |
| PT1156795E (pt) | 2004-09-30 |
| ES2222717T3 (es) | 2005-02-01 |
| DK1156795T3 (da) | 2004-11-01 |
| DE69917809T2 (de) | 2004-11-04 |
| CA2366073A1 (en) | 2000-09-08 |
| EP1156795A1 (de) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200401284A1 (ru) | Замещённые бензазолы и их применение в качестве ингибиторов киназы raf | |
| WO2005047244A3 (en) | Inhibition of fgfr3 and treatment of multiple myeloma | |
| UA85055C2 (ru) | Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний | |
| IL149890A0 (en) | Tnt-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated | |
| ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
| CY1108720T1 (el) | Διαρυλ υποκατεστημενα τριαζολια ως αναστολεις διαυλου νατριου | |
| DK1539166T3 (da) | Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme | |
| YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
| PT950057E (pt) | Enantiomeros de 3-piridilo e sua utilizacao como analgesicos | |
| DE60315479D1 (de) | Pyrimidinamid derivate und deren verwendung | |
| ATE287267T1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
| EA200500803A1 (ru) | Антагонисты ccr1 для лечения воспалительных артритов, демиелинизационных воспалительных заболеваний | |
| ATE453402T1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
| EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
| DE69917809D1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| EA200100930A1 (ru) | Способ лечения хозл | |
| DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
| DE69733557D1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
| DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
| SE0103795D0 (sv) | Compounds and method for the treatment of överactive bladder | |
| EA199800819A1 (ru) | Способ лечения биполярного расстройства | |
| ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| EA199900174A1 (ru) | Способ лечения биполярного расстройства | |
| DE602004016547D1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| DE50012667D1 (de) | Verwendung von 2-amino-3,4-dihydro-chinazolinen zur herstellung eines medikaments zur behandlung oder prophylaxe von ischämischen zuständen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: BUDDHA BIOPHARMA OY LTD., HELSINKI, FI |